Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Smith

Showing results (351-360 of 368) with videos related to

Pageof 37
Sort By:
Nature Communications|August 30, 2020
Incorporating hydrology into climate suitability models changes projections of malaria transmission in AfricaM W Smith, T Willis, L Alfieri, et al.
Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivativesC H Lin, S R Haadsma-Svensson, G Phillips, et al.
Vaccine|March 8, 2008
Detecting AIDS restriction genes: from candidate genes to genome-wide association discoveryH B Hutcheson, J A Lautenberger, G W Nelson, et al.
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolitesR F Heier, L A Dolak, J N Duncan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10H D Shin, C Winkler, J C Stephens, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 2, 1998
Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progressionH Hendel, N Hénon, H Lebuanec, et al.
Journal of Medical Genetics|June 7, 2005
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanomaK Laud, C Marian, M F Avril, et al.
Journal of Medicinal Chemistry|June 21, 1996
(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonistR E TenBrink, C L Bergh, J N Duncan, et al.
Journal of Medicinal Chemistry|December 14, 2001
Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindansS R Haadsma-Svensson, K A Cleek, D M Dinh, et al.
Science (New York, N.Y.)|September 27, 1996
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE StudyM Dean, M Carrington, C Winkler, et al.
Pageof 37

Showing results (351-360 of 368) with videos related to

Sort By:
Pageof 37
Nature Communications|August 30, 2020
Incorporating hydrology into climate suitability models changes projections of malaria transmission in AfricaM W Smith, T Willis, L Alfieri, et al.
Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivativesC H Lin, S R Haadsma-Svensson, G Phillips, et al.
Vaccine|March 8, 2008
Detecting AIDS restriction genes: from candidate genes to genome-wide association discoveryH B Hutcheson, J A Lautenberger, G W Nelson, et al.
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolitesR F Heier, L A Dolak, J N Duncan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10H D Shin, C Winkler, J C Stephens, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 2, 1998
Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progressionH Hendel, N Hénon, H Lebuanec, et al.
Journal of Medical Genetics|June 7, 2005
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanomaK Laud, C Marian, M F Avril, et al.
Journal of Medicinal Chemistry|June 21, 1996
(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonistR E TenBrink, C L Bergh, J N Duncan, et al.
Journal of Medicinal Chemistry|December 14, 2001
Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindansS R Haadsma-Svensson, K A Cleek, D M Dinh, et al.
Science (New York, N.Y.)|September 27, 1996
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE StudyM Dean, M Carrington, C Winkler, et al.
Pageof 37